How long is the course of treatment with Alpelisib?

The length of treatment with Alpelisib (Alpelisib) is usually determined based on the patient's specific condition, disease characteristics, treatment response and other factors. At present, Apelvis is mainly used to treat breast cancer, especially HR-positive (hormone receptor positive) and HER2-negative (human epidermal growth factor receptor 2 negative) advanced breast cancer patients, and these patients must have PIK3CA gene mutations.

Generally speaking, apelvis, as an oral medication, needs to be continued until disease progression or intolerable side effects occur. The exact length of a course of treatment may vary based on individual differences, the severity of the condition, and the patient's response to the medication. In breast cancer patients, the course of treatment is often long-term and may take several months or longer.

Doctors will conduct regular assessment and monitoring based on the patient's condition to adjust the treatment plan to ensure the best treatment effect. During the course of treatment, patients may undergo various examinations, including imaging examinations, laboratory tests, etc., to evaluate the progression of the disease and monitor possible side effects.

It is important that patients follow their doctor's advice while taking Apelvis and have regular follow-up visits. If any discomfort or concerns arise, they should be reported to the medical team promptly so that adjustments or treatments can be made promptly.

Apelis has not yet been launched in China, so it is not included in medical insurance. Therefore, patients cannot purchase it domestically and need to purchase Apelis through overseas channels. In foreign countries, the original Apelvis drug is mainly used. There are European and Indian versions of the original drug on the market. The price of the European version of the original drug is as high as tens of thousands of yuan. Relatively speaking, the price of the Indian version of the original drug is around four to five thousand yuan. The price is still relatively cheap. Moreover, the ingredients and efficacy of the European and Indian original drugs are consistent.